Meeting to be held on May 2 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on NBIX: Neurocrine Biosciences Reports First Quarter 2024 Financial Results Neurocrine announces FDA approval of INGREZZA SPRINKLE capsules Neurocrine management to meet with Oppenheimer NBIX Upcoming Earnings Report: What to Expect? Tesla, Airbnb upgraded: Wall Street’s top analyst calls